drugset / Trial / NCT00223158
Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer
RandomizedParallel-groupDouble-blindTreatment
Summary
To compare the hypothyroid state in patients with thyroid cancer prepared either by placebo or L-T3 following L-T4 withdrawal in preparation for whole body scintigraphy. To evaluate the time needed for TSH elevation (\> 30 mUI/L) on placebo vs. L-T3.
Timeline
- Start
- 2003-09
- Primary completion
- 2005-05
- Completion
- 2005-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Liothyronine | Small molecule | 50 mg | — |